These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475 [TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids. Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580 [TBL] [Abstract][Full Text] [Related]
4. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles. Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817 [TBL] [Abstract][Full Text] [Related]
5. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
6. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat. Groener JE; van Gent T; van Tol A Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808 [TBL] [Abstract][Full Text] [Related]
7. Action of ciprofibrate in type IIb hyperlipoproteinemia: modulation of the atherogenic lipoprotein phenotype and stimulation of high-density lipoprotein-mediated cellular cholesterol efflux. Guerin M; Le Goff W; Frisdal E; Schneider S; Milosavljevic D; Bruckert E; Chapman MJ J Clin Endocrinol Metab; 2003 Aug; 88(8):3738-46. PubMed ID: 12915663 [TBL] [Abstract][Full Text] [Related]
8. Atherogenic hyperlipoproteinemia. The cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Mahley RW Med Clin North Am; 1982 Mar; 66(2):375-402. PubMed ID: 7040843 [TBL] [Abstract][Full Text] [Related]
9. [Molecular biology of reverse cholesterol transport system and impairment of the protection system against atherosclerosis]. Yamashita S; Matsuzawa Y Nihon Rinsho; 1993 Jun; 51(6):1684-91. PubMed ID: 8320848 [TBL] [Abstract][Full Text] [Related]
10. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM). Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840 [TBL] [Abstract][Full Text] [Related]
11. Effects of feeding fish oil on the properties of lipoproteins isolated from rhesus monkeys consuming an atherogenic diet. Soltys PA; Mazzone T; Wissler RW; Vahed S; Rangnekar V; Lukens J; Vesselinovitch D; Getz GS Atherosclerosis; 1989 Apr; 76(2-3):103-15. PubMed ID: 2730707 [TBL] [Abstract][Full Text] [Related]
12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related]
13. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease]. Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538 [TBL] [Abstract][Full Text] [Related]
14. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]